Ensysce Biosciences Inc · ENSC.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $7.45M − (Liabilities $4.57M + Equity $3.21M) = -$328.97K · out of balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$4.31M
57.8%
$808.28K
23.1%
Assets
Receivables
$420.35K
5.6%
$296.23K
238.7%
Assets
Other current assets
$2.51M
33.7%
$793.28K
46.2%
Assets
Other
$210.01K
2.8%
-$42.54K
-16.8%
Liabilities + Equity
Accounts payable
$3.27M
42.0%
$1.91M
140.8%
Liabilities + Equity
Short-term debt
$306.71K
3.9%
$5.05K
1.7%
Liabilities + Equity
Other liabilities
$993.41K
12.8%
$434.86K
77.9%
Liabilities + Equity
Equity
$3.21M
41.3%
-$494.70K
-13.3%